Catheter treatment of tachyarrhythmias in children under 5 years old using thermal mapping and discrete applications

  • M. Meshkova Ukrainian Children’s Cardiac Center (Kyiv)
  • A. Doronin Ukrainian Children’s Cardiac Center (Kyiv); Ukrainian National Medical Postgraduate Academy (Kyiv)
  • V. Khanenova Ukrainian Children’s Cardiac Center (Kyiv)
  • D. Zabashta Ukrainian Children’s Cardiac Center (Kyiv)
  • N. Rudenko Ukrainian Children’s Cardiac Center (Kyiv); Ukrainian National Medical Postgraduate Academy (Kyiv)
Keywords: tachyarrhythmias, children, catheter ablation

Abstract

Radiofrequency catheter ablation (RCA) for the treatment of tachyarrhythmias in children under the age 5 years is not used as often as in patients of other age groups. The RCA procedure has great advantages over chronic antiarrhythmic therapy, but its use in young children is limited due to specific complications.

The objective is to analyse our own experience in catheter treatment for tachyarrhythmias in children under the age of 5 years using the method of thermoal mapping and discrete applications.

Material and methods. The article presents the results of 68 RCA in 56 consecutive patients under the age of 5 years old, who underwent surgical interventions from 2007 to 2017. Ablations of accessory pathways were more frequent among the procedures. There were 12 (17.9%) reoperations. The immediate efficacy of RFA was 88.0%, after reoperations – 96.0%. 5 (7.3%) complications were reported, of which 2 (2.9%) were significant. There was no mortality.

RCA was carried out by one or two 6F (with a body weight of up to 15 kg) or 7F non-irrigated catheters with a 4-mm distal pole. The parameters of applications did not exceed 53°С, 35 W, 40 s. After 2011, the applications were applied discretely at (45 °C →48 °C →50 °C →53 °C) and after thermal mapping.

Results and discussion. After the introduction of clear indications to RCA in young children in 2011, despite an annual increase in the number of children with tachyarrhythmia treated in our clinic, the percentage of ablation performed at early age decreased.

Since 2012, ablations were performed in older children with a greater body weight. At the same time, despite the greater number of RCA in children younger than 5 years old during this period, there were no complications, and the success of procedures increased from 85% to 91%.

We associate the growth of RCA direct success with the fact that we were able to avoid urgent procedures and procedures in decompensated patients.

A new treatment protocol and less aggressive, well-defined indications for RCA in children under the age 5 years have allowed us to reduce the number of ablation at earlier age when the probability of complications is greatest.

The ‘gentle’ RCA method allows us to make sure that the application in the selected place was safe, and in case of adverse effects – to immediately stop it without irreversible consequences. The advantages of this technique are confirmed by the absence of complications associated with RCA after the new method implementation.

Since 2012 we have had a higher percentage of reoperations (up to 18%), but all of them were performed at older age. We consider this to be justified in the absence of complications and high efficacy of RCA.

References

  1. Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016; 133:e506–e574. https://doi:10.1161/CIR.0000000000000311
  2. Backhoff D, Klehs S, Mьller MJ, Schneider H, Kriebel T, Paul T, et al. Radiofrequency catheter ablation of accessory atrioventricular pathways in infants and toddlers ≤ 15 kg. Pediatr Cardiol. 2016;37(5):892–8. https://doi.org/10.1007/s00246-016-1365-z
  3. Kugler JD, Danford DA, Deal BJ, Gillette PC, Perry JC, Silka MJ, et al. Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. The Pediatric Electrophysiology Society. N. Engl. J. Med. 1994;330(21):1481–7. https://doi.org/10.1056/NEJM199405263302103
  4. Kugler JD, Danford DA, Houston KA, Felix G; Pediatric Radiofrequency Ablation Registry of the Pediatric Radiofrequency Ablation Registry of the Pediatric Electrophysiology Society. Pediatric radiofrequency catheter ablation registry success, fluoroscopy time, and complication rate for supraventricular tachycardia: comparison of early and recent eras. J Cardiovasc Electrophysiol. 2002 Apr;13(4):336–41.
  5. Greyling A, Ector J, Garweg C. Radiofrequency catheter ablation in infants and children. SA Heart. 2017;14:16–20. https://doi.org/10.24170/14-1-1864
  6. An HS, Choi EY, Kwon BS, Kim GB, Bae EJ, Noh CI, et al. Radiofrequency catheter ablation for supraventricular tachycardia: a comparison study of children aged 0-4 and 5-9 years. Pacing Clin Electrophysiol. 2013;36(12):1488– 94. https://doi.org/10.1111/pace.12267
  7. Radbill AE, Fish FA. Mapping and ablation of supraventricular tachycardia in pediatric and congenital heart disease patients. Prog. Pediatr. Cardiol. 2013;35(1):65– 77. https://doi.org/10.1016/j.ppedcard.2012.11.009
  8. Pilcher TA, Saarel EV. Anatomic Challenges In Pediatric Catheter Ablation. J Atr Fibrillation. 2014;7(2):1054. https://doi.org/10.4022/jafib.1054
  9. Brugada J, Blom N, Sarquella-Brugada G, Blomstrom-Lundqvist C, Deanfield J, Janousek J, et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace. 2013;15(9):1337–82. https://doi.org/10.1093/europace/eut082 procedures increased from 85% to 91%.
Published
2019-03-11
How to Cite
Meshkova, M., Doronin, A., Khanenova, V., Zabashta, D., & Rudenko, N. (2019). Catheter treatment of tachyarrhythmias in children under 5 years old using thermal mapping and discrete applications. Ukrainian Journal of Cardiovascular Surgery, (1 (34), 55-58. https://doi.org/10.30702/ujcvs/19.35/13(055-058)
Section
NEW TREATMENTS FOR CARDIOVASCULAR DISEASES

Most read articles by the same author(s)

1 2 > >>